Dr Felix Frueh | CSO and Co-Founder
Selva Therapeutics, Inc.

Dr Felix Frueh, CSO and Co-Founder, Selva Therapeutics, Inc.

Dr. Frueh was previously CSO at Human Longevity, Inc. He was the President of the Medco Research Institute and the first Associate Director for Genomics at FDA. In addition, he held executive positions in multiple biotechnology companies and serves on the Boards of several biotechnology corporations and non-profit organizations. Dr. Frueh is a Fellow of the American College of Clinical Pharmacology and held faculty positions at Georgetown University in Washington, DC and at the University of North Carolina.

Appearances:



WVIC/WAC Day 2 - Nov 30 @ 15:30

Showcase 5: Broadly acting cathepsins inhibitor against omicron and other variants of concern

last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard

lauren.sheppard@terrapinn.com

For sponsorship and exhibition opportunities:
Thomas Hall

thomas.hall@terrapinn.com